Bharat Biotech on May 24, 2021 began trials for the booster dose of Covaxin at AIIMS, Delhi and Patna. The booster trials will be conducted in phase two clinical trial participants.
from Jagran Josh https://ift.tt/3vupCZD
Bharat Biotech on May 24, 2021 began trials for the booster dose of Covaxin at AIIMS, Delhi and Patna. The booster trials will be conducted in phase two clinical trial participants.
Get All The Latest Updates Delivered Straight Into Your Inbox For Free!
No comments:
Post a Comment